{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SEC61A1\n",
    "SEC61 complex, alpha-1 subunit (SEC61A1), is a subunit of the heteromeric SEC61 complex, which also contains beta (SEC61B; 609214) and gamma (SEC61G; 609215) subunits. The SEC61 complex forms the core of the mammalian endoplasmic reticulum (ER) translocon (See [OMIM:609213]). Pathogenic variants in SEC61A1 are associated with\n",
    "[Neutropenia, severe congenital, 11, autosomal dominant (OMIM:620674)](https://omim.org/entry/620674),\n",
    "[Immunodeficiency, common variable, 15 (OMIM:620670)](https://omim.org/entry/620670), and\n",
    "[Tubulointerstitial kidney disease, autosomal dominant, 5 (OMIM:617056)](https://omim.org/entry/617056)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded HPO v2025-01-16\n",
      "Using gpsea version 0.9.6.dev0\n"
     ]
    }
   ],
   "source": [
    "import gpsea\n",
    "import hpotk\n",
    "\n",
    "store = hpotk.configure_ontology_store()\n",
    "hpo = store.load_minimal_hpo()\n",
    "print(f'Loaded HPO v{hpo.version}')\n",
    "print(f\"Using gpsea version {gpsea.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gpsea.preprocessing import configure_default_protein_metadata_service\n",
    "\n",
    "gene_symbol = 'SEC61A1'\n",
    "mane_tx_id = 'NM_013336.4'\n",
    "mane_protein_id = 'NP_037468.1' # protein transport protein Sec61 subunit alpha isoform 1 isoform 1\n",
    "pms = configure_default_protein_metadata_service()\n",
    "protein_meta = pms.annotate(mane_protein_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Individuals Processed: 100%|██████████| 19/19 [00:00<00:00, 163.17 individuals/s]\n",
      "Validated under permissive policy\n",
      "No errors or warnings were found\n"
     ]
    }
   ],
   "source": [
    "from ppktstore.registry import configure_phenopacket_registry\n",
    "from gpsea.preprocessing import configure_caching_cohort_creator, load_phenopackets\n",
    "\n",
    "phenopacket_store_release = '0.1.24'  \n",
    "registry = configure_phenopacket_registry()\n",
    "\n",
    "with registry.open_phenopacket_store(release=phenopacket_store_release) as ps:\n",
    "    cdls6_phenopackets = tuple(ps.iter_cohort_phenopackets(gene_symbol))\n",
    "\n",
    "cohort_creator   = configure_caching_cohort_creator(hpo)\n",
    "cohort, qc = load_phenopackets(\n",
    "    phenopackets=cdls6_phenopackets, \n",
    "    cohort_creator=cohort_creator,\n",
    ")\n",
    "qc.summarize()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "    <style>\n",
       "        /** Light theme is the default */\n",
       "        :root {\n",
       "            --gpsea-color-text: black;\n",
       "            --gpsea-color-link-text: rgb(0, 118, 187);\n",
       "            --gpsea-color-link-hover: rgb(0, 99, 156);\n",
       "            --gpsea-color-primary-a0: #2f5170;\n",
       "            --gpsea-color-primary-a10: #4778a5;\n",
       "            --gpsea-color-primary-a20: #5995ce;\n",
       "            --gpsea-color-primary-a60: LightSkyBlue;\n",
       "            --gpsea-color-surface-a0: #fcfcfc;\n",
       "            --gpsea-color-surface-a10: #ffffff;\n",
       "            --gpsea-color-surface-a20: #b3b3b3;\n",
       "            --gpsea-color-surface-a30: #8d8d8d;\n",
       "            --gpsea-color-surface-a40: #646464;\n",
       "            --gpsea-color-surface-a50: #000000;\n",
       "        }\n",
       "\n",
       "        /** Dark theme */\n",
       "        /*\n",
       "        @media (prefers-color-scheme: dark) {\n",
       "            :root {\n",
       "                --gpsea-color-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-hover: lightblue;\n",
       "                --gpsea-color-primary-a0: #64a3df;\n",
       "                --gpsea-color-primary-a10: #5286b8;\n",
       "                --gpsea-color-primary-a20: #375c7e;\n",
       "                --gpsea-color-primary-a60: #233b52;\n",
       "                --gpsea-color-surface-a0: #121212;\n",
       "                --gpsea-color-surface-a10: #282828;\n",
       "                --gpsea-color-surface-a20: #3f3f3f;\n",
       "                --gpsea-color-surface-a30: #575757;\n",
       "                --gpsea-color-surface-a40: #717171;\n",
       "                --gpsea-color-surface-a50: #8b8b8b;\n",
       "            }\n",
       "        }\n",
       "        */\n",
       "\n",
       "        #gpsea-body {\n",
       "            max-width: 1600px;\n",
       "            color: var(--gpsea-color-text);\n",
       "            background-color: var(--gpsea-color-surface-a0);\n",
       "            padding: 10px 0;\n",
       "        }\n",
       "\n",
       "        #gpsea-body {\n",
       "\n",
       "            h1,\n",
       "            h2,\n",
       "            h3,\n",
       "            h4,\n",
       "            h5 {\n",
       "                color: var(--gpsea-color-primary-a0);\n",
       "            }\n",
       "\n",
       "            a {\n",
       "                color: var(--gpsea-color-link-text);\n",
       "                text-decoration: none;\n",
       "            }\n",
       "\n",
       "            a:hover {\n",
       "                color: var(--gpsea-color-link-hover);\n",
       "            }\n",
       "\n",
       "            #cohort-summary {\n",
       "                max-width: 800px;\n",
       "            }\n",
       "\n",
       "            td {\n",
       "                padding: 5px 0;\n",
       "            }\n",
       "\n",
       "            .cards {\n",
       "                display: flex;\n",
       "                flex-flow: row wrap;\n",
       "                align-items: top;\n",
       "                gap: 1rem;\n",
       "            }\n",
       "\n",
       "            .card {\n",
       "                border-radius: 5px;\n",
       "                padding: 0px 10px;\n",
       "                background: var(--gpsea-color-surface-a10);\n",
       "                border: 1px solid var(--gpsea-color-surface-a30);\n",
       "                box-shadow: 0 4px 8px var(--gpsea-color-surface-a30);\n",
       "            }\n",
       "\n",
       "            table {\n",
       "                width: 100%;\n",
       "                border-collapse: collapse;\n",
       "                margin: 10px 0;\n",
       "                font-size: 0.9em;\n",
       "                font-family: sans-serif;\n",
       "                box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "                border: 1px solid var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            th {\n",
       "                text-align: left;\n",
       "                padding: 2px;\n",
       "                font-weight: bold;\n",
       "                font-size: 120%;\n",
       "                color: var(--gpsea-color-text);\n",
       "                background-color: var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            table td,\n",
       "            tr {\n",
       "                text-align: left;\n",
       "                padding: 0px 5px;\n",
       "            }\n",
       "\n",
       "            tr:nth-child(even) {\n",
       "                background-color: var(--gpsea-color-surface-a10);\n",
       "            }\n",
       "\n",
       "            tr:nth-child(odd) {\n",
       "                background-color: var(--gpsea-color-surface-a20);\n",
       "            }\n",
       "\n",
       "            caption {\n",
       "                caption-side: top;\n",
       "                text-align: left;\n",
       "                padding-bottom: 10px;\n",
       "                font-weight: bold;\n",
       "            }\n",
       "        }\n",
       "    </style>\n",
       "    <div id=\"gpsea-body\">\n",
       "        \n",
       "\n",
       "<h1>GPSEA cohort analysis</h1>\n",
       "<div id=\"cohort-summary\">\n",
       "  <p>\n",
       "    Successfully loaded 19 individuals.\n",
       "\n",
       "    \n",
       "    11 were recorded as male,\n",
       "    8 as female,\n",
       "    and 0 as unknown sex.\n",
       "\n",
       "    \n",
       "    \n",
       "    6 were reported to be alive at the time of last encounter,\n",
       "    1 was deceased,\n",
       "    and vital status was unreported for 12 individuals.\n",
       "    \n",
       "\n",
       "    \n",
       "    16 individuals had disease onset information\n",
       "    and 1 had information about the age of last encounter.\n",
       "  </p>\n",
       "\n",
       "  \n",
       "  <p>No errors encountered.</p>\n",
       "  \n",
       "</div>\n",
       "\n",
       "\n",
       "<div class=\"cards\">\n",
       "  \n",
       "  <div id=\"hpo\" class=\"card\">\n",
       "    <h2>HPO terms</h2>\n",
       "    \n",
       "    \n",
       "    <table>\n",
       "      The cohort included 76 distinct HPO terms.\n",
       "      <caption>\n",
       "        \n",
       "        Top 10 most common HPO terms.\n",
       "        \n",
       "        \n",
       "      </caption>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>HPO Term</th>\n",
       "        </tr>\n",
       "\n",
       "        \n",
       "        <tr>\n",
       "          <td>10</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0004315\">Decreased circulating IgG concentration</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>10</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0410302\">Decreased specific antibody response to protein-conjugated polysaccharide vaccine</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>9</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0410299\">Decreased specific antibody response to polysaccharide vaccine</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>8</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0002720\">Decreased circulating IgA concentration</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0002850\">Decreased circulating total IgM</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0001518\">Small for gestational age</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0003259\">Elevated circulating creatinine concentration</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0001903\">Anemia</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0000403\">Recurrent otitis media</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>5</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/term/HP:0012622\">Chronic kidney disease</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div id=\"measurements\" class=\"card\">\n",
       "    <h2>Measurements</h2>\n",
       "    \n",
       "    \n",
       "    No data regarding measurement assays were provided.\n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div id=\"diseases\" class=\"card\">\n",
       "    <h2>Diseases</h2>\n",
       "    \n",
       "    \n",
       "    The cohort members were diagnosed with 3 diseases.\n",
       "    <table>\n",
       "      \n",
       "\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>Disease</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>11</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/disease/OMIM:620670\">Immunodeficiency, common variable, 15</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>7</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/disease/OMIM:617056\">Tubulointerstitial kidney disease, autosomal dominant, 5</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>1</td>\n",
       "          <td><a href=\"https://hpo.jax.org/browse/disease/OMIM:620674\">Neutropenia, severe congenital, 11, autosomal dominant</a>\n",
       "          </td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "  </div>\n",
       "\n",
       "  \n",
       "  \n",
       "  <div class=\"card\">\n",
       "    <h2>Variants</h2>\n",
       "    <p>\n",
       "      A total of 6 unique variants\n",
       "      were identified in the cohort. Variants were annotated with respect to NM_013336.4.\n",
       "    </p>\n",
       "    <table>\n",
       "      <caption>\n",
       "        <h3>Top 10 variants</h3>\n",
       "      </caption>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th><em>n</em></th>\n",
       "          <th>Variant key</th>\n",
       "          <th>HGVS</th>\n",
       "          <th>Variant Class</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>9</td>\n",
       "          <td>3_128056742_128056742_T_A</td>\n",
       "          <td>c.254T>A (p.Val85Asp)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>4</td>\n",
       "          <td>3_128060598_128060598_A_G</td>\n",
       "          <td>c.553A>G (p.Thr185Ala)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>3_128055731_128055731_T_G</td>\n",
       "          <td>c.200T>G (p.Val67Gly)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>2</td>\n",
       "          <td>3_128067586_128067586_G_T</td>\n",
       "          <td>c.1141G>T (p.Glu381Ter)</td>\n",
       "          <td>STOP_GAINED</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>1</td>\n",
       "          <td>3_128056763_128056763_A_G</td>\n",
       "          <td>c.275A>G (p.Gln92Arg)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>1</td>\n",
       "          <td>3_128069603_128069603_T_G</td>\n",
       "          <td>c.1372T>G (p.Phe458Val)</td>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "  </div>\n",
       "\n",
       "  \n",
       "  <div class=\"card\">\n",
       "    \n",
       "    <h2>Variant effects</h2>\n",
       "    <p>\n",
       "      The effects were predicted for NM_013336.4\n",
       "    </p>\n",
       "    <table>\n",
       "      <tbody>\n",
       "        <tr class=\"strng\">\n",
       "          <th>Variant effect</th>\n",
       "          <th>Count</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>MISSENSE_VARIANT</td>\n",
       "          <td>17 (89%)</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          <td>STOP_GAINED</td>\n",
       "          <td>2 (11%)</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "    </table>\n",
       "    \n",
       "  </div>\n",
       "</div>\n",
       "\n",
       "    </div>\n",
       "</div>"
      ],
      "text/plain": [
       "<gpsea.view._base.HtmlGpseaReport at 0x7e8dec6232f0>"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import CohortViewer\n",
    "\n",
    "cv = CohortViewer(hpo)\n",
    "cv.process(cohort, transcript_id=mane_tx_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from gpsea.view import ProteinVisualizer\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "sec61a1_fig, ax = plt.subplots(figsize=(15, 8))\n",
    "visualizer = ProteinVisualizer()\n",
    "visualizer.draw_protein(\n",
    "    protein_metadata=protein_meta,\n",
    "    cohort=cohort,\n",
    "    ax=ax,\n",
    ")\n",
    "sec61a1_fig.tight_layout()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Genotype-Phenotype Correlation (GPC) Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gpsea.analysis.pcats import configure_hpo_term_analysis\n",
    "from gpsea.analysis.clf import prepare_classifiers_for_terms_of_interest\n",
    "\n",
    "analysis = configure_hpo_term_analysis(hpo)\n",
    "pheno_clfs = prepare_classifiers_for_terms_of_interest(\n",
    "    cohort=cohort,\n",
    "    hpo=hpo,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "    <style>\n",
       "        /** Light theme is the default */\n",
       "        :root {\n",
       "            --gpsea-color-text: black;\n",
       "            --gpsea-color-link-text: rgb(0, 118, 187);\n",
       "            --gpsea-color-link-hover: rgb(0, 99, 156);\n",
       "            --gpsea-color-primary-a0: #2f5170;\n",
       "            --gpsea-color-primary-a10: #4778a5;\n",
       "            --gpsea-color-primary-a20: #5995ce;\n",
       "            --gpsea-color-primary-a60: LightSkyBlue;\n",
       "            --gpsea-color-surface-a0: #fcfcfc;\n",
       "            --gpsea-color-surface-a10: #ffffff;\n",
       "            --gpsea-color-surface-a20: #b3b3b3;\n",
       "            --gpsea-color-surface-a30: #8d8d8d;\n",
       "            --gpsea-color-surface-a40: #646464;\n",
       "            --gpsea-color-surface-a50: #000000;\n",
       "        }\n",
       "\n",
       "        /** Dark theme */\n",
       "        /*\n",
       "        @media (prefers-color-scheme: dark) {\n",
       "            :root {\n",
       "                --gpsea-color-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-text: rgb(240, 240, 240);\n",
       "                --gpsea-color-link-hover: lightblue;\n",
       "                --gpsea-color-primary-a0: #64a3df;\n",
       "                --gpsea-color-primary-a10: #5286b8;\n",
       "                --gpsea-color-primary-a20: #375c7e;\n",
       "                --gpsea-color-primary-a60: #233b52;\n",
       "                --gpsea-color-surface-a0: #121212;\n",
       "                --gpsea-color-surface-a10: #282828;\n",
       "                --gpsea-color-surface-a20: #3f3f3f;\n",
       "                --gpsea-color-surface-a30: #575757;\n",
       "                --gpsea-color-surface-a40: #717171;\n",
       "                --gpsea-color-surface-a50: #8b8b8b;\n",
       "            }\n",
       "        }\n",
       "        */\n",
       "\n",
       "        #gpsea-body {\n",
       "            max-width: 1600px;\n",
       "            color: var(--gpsea-color-text);\n",
       "            background-color: var(--gpsea-color-surface-a0);\n",
       "            padding: 10px 0;\n",
       "        }\n",
       "\n",
       "        #gpsea-body {\n",
       "\n",
       "            h1,\n",
       "            h2,\n",
       "            h3,\n",
       "            h4,\n",
       "            h5 {\n",
       "                color: var(--gpsea-color-primary-a0);\n",
       "            }\n",
       "\n",
       "            a {\n",
       "                color: var(--gpsea-color-link-text);\n",
       "                text-decoration: none;\n",
       "            }\n",
       "\n",
       "            a:hover {\n",
       "                color: var(--gpsea-color-link-hover);\n",
       "            }\n",
       "\n",
       "            #cohort-summary {\n",
       "                max-width: 800px;\n",
       "            }\n",
       "\n",
       "            td {\n",
       "                padding: 5px 0;\n",
       "            }\n",
       "\n",
       "            .cards {\n",
       "                display: flex;\n",
       "                flex-flow: row wrap;\n",
       "                align-items: top;\n",
       "                gap: 1rem;\n",
       "            }\n",
       "\n",
       "            .card {\n",
       "                border-radius: 5px;\n",
       "                padding: 0px 10px;\n",
       "                background: var(--gpsea-color-surface-a10);\n",
       "                border: 1px solid var(--gpsea-color-surface-a30);\n",
       "                box-shadow: 0 4px 8px var(--gpsea-color-surface-a30);\n",
       "            }\n",
       "\n",
       "            table {\n",
       "                width: 100%;\n",
       "                border-collapse: collapse;\n",
       "                margin: 10px 0;\n",
       "                font-size: 0.9em;\n",
       "                font-family: sans-serif;\n",
       "                box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "                border: 1px solid var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            th {\n",
       "                text-align: left;\n",
       "                padding: 2px;\n",
       "                font-weight: bold;\n",
       "                font-size: 120%;\n",
       "                color: var(--gpsea-color-text);\n",
       "                background-color: var(--gpsea-color-primary-a60);\n",
       "            }\n",
       "\n",
       "            table td,\n",
       "            tr {\n",
       "                text-align: left;\n",
       "                padding: 0px 5px;\n",
       "            }\n",
       "\n",
       "            tr:nth-child(even) {\n",
       "                background-color: var(--gpsea-color-surface-a10);\n",
       "            }\n",
       "\n",
       "            tr:nth-child(odd) {\n",
       "                background-color: var(--gpsea-color-surface-a20);\n",
       "            }\n",
       "\n",
       "            caption {\n",
       "                caption-side: top;\n",
       "                text-align: left;\n",
       "                padding-bottom: 10px;\n",
       "                font-weight: bold;\n",
       "            }\n",
       "        }\n",
       "    </style>\n",
       "    <div id=\"gpsea-body\">\n",
       "        \n",
       "<h1>Phenotype testing report</h1>\n",
       "<div class=\"cards\">\n",
       "  <div class=\"card\">\n",
       "    <ul>\n",
       "      <li>Phenotype MTC filter: <em>Independent filtering HPO filter</em></li>\n",
       "      <li>Multiple testing correction: <em>fdr_bh</em></li>\n",
       "    </ul>\n",
       "  </div>\n",
       "  <div class=\"card\">\n",
       "    <table>\n",
       "      <tbody>\n",
       "        <tr>\n",
       "          <th>Reason</th>\n",
       "          <th>Count</th>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skip-terms-if-all-counts-are-identical-to-counts-for-a-child-term\">Skip terms if all counts are identical to counts for a child term</a></td>\n",
       "          \n",
       "          <td>3</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skip-term-if-one-of-the-genotype-groups-has-neither-observed-nor-excluded-observations\">Skipping term because one genotype had zero observations</a></td>\n",
       "          \n",
       "          <td>6</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skipping-general-level-terms\">Skipping \"general\" level terms</a></td>\n",
       "          \n",
       "          <td>76</td>\n",
       "        </tr>\n",
       "        \n",
       "        <tr>\n",
       "          \n",
       "            <td><a href=\"https://P2GX.github.io/gpsea/stable/user-guide/analyses/mtc.html#skipping-terms-that-are-rare-on-the-cohort-level\">Skipping terms that are rare on the cohort level (in less than 40% of the cohort members)</a></td>\n",
       "          \n",
       "          <td>162</td>\n",
       "        </tr>\n",
       "        \n",
       "      </tbody>\n",
       "      <caption>\n",
       "        Performed statistical tests for 24 out of the total of 271 HPO terms.\n",
       "      </caption>\n",
       "    </table>\n",
       "  </div>\n",
       "</div>\n",
       "\n",
       "    </div>\n",
       "</div>"
      ],
      "text/plain": [
       "<gpsea.view._base.HtmlGpseaReport at 0x7e8e186a8fb0>"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import MtcStatsViewer\n",
    "from gpsea.analysis.predicate import variant_key\n",
    "from gpsea.analysis.clf import monoallelic_classifier\n",
    "\n",
    "val85asp = variant_key(\"3_128056742_128056742_T_A\") # p.Val85Asp\n",
    "val85asp_clf = monoallelic_classifier(\n",
    "    a_predicate=val85asp,\n",
    "    b_predicate= ~val85asp,\n",
    "    a_label='p.Val85Asp', \n",
    "    b_label='Other variant'\n",
    ")\n",
    "val85asp_result = analysis.compare_genotype_vs_phenotypes(\n",
    "    cohort=cohort,\n",
    "    gt_clf=val85asp_clf,\n",
    "    pheno_clfs=pheno_clfs,\n",
    ")\n",
    "viewer = MtcStatsViewer()\n",
    "viewer.process(val85asp_result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "p.Val85Asp",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Other variant",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Corrected p values",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "p values",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "c3decb31-532d-43d9-b7e8-699cdf6888ce",
       "rows": [
        [
         "Recurrent lower respiratory tract infections [HP:0002783]",
         "6/6 (100%)",
         "0/5 (0%)",
         "0.05194805194805195",
         "0.0021645021645021645"
        ],
        [
         "Elevated circulating creatinine concentration [HP:0003259]",
         "0/4 (0%)",
         "7/8 (88%)",
         "0.08080808080808081",
         "0.010101010101010102"
        ],
        [
         "Anemia [HP:0001903]",
         "0/4 (0%)",
         "7/8 (88%)",
         "0.08080808080808081",
         "0.010101010101010102"
        ],
        [
         "Recurrent respiratory infections [HP:0002205]",
         "6/6 (100%)",
         "1/6 (17%)",
         "0.08727272727272727",
         "0.01515151515151515"
        ],
        [
         "Decreased circulating IgA concentration [HP:0002720]",
         "8/9 (89%)",
         "0/3 (0%)",
         "0.08727272727272727",
         "0.01818181818181818"
        ],
        [
         "Recurrent infections [HP:0002719]",
         "8/8 (100%)",
         "5/10 (50%)",
         "0.13636363636363635",
         "0.03594771241830065"
        ],
        [
         "Decreased circulating total IgM [HP:0002850]",
         "7/9 (78%)",
         "0/3 (0%)",
         "0.13636363636363635",
         "0.04545454545454545"
        ],
        [
         "Decreased circulating IgG concentration [HP:0004315]",
         "9/9 (100%)",
         "1/3 (33%)",
         "0.13636363636363635",
         "0.04545454545454545"
        ],
        [
         "Recurrent upper respiratory tract infections [HP:0002788]",
         "2/2 (100%)",
         "1/6 (17%)",
         "0.28571428571428575",
         "0.10714285714285715"
        ],
        [
         "Sepsis [HP:0100806]",
         "1/9 (11%)",
         "1/3 (33%)",
         "1.0",
         "0.45454545454545453"
        ],
        [
         "Frequent Giardia lamblia infestation [HP:0005215]",
         "1/9 (11%)",
         "0/7 (0%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent bronchitis [HP:0002837]",
         "1/9 (11%)",
         "0/7 (0%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent tonsillitis [HP:0011110]",
         "1/9 (11%)",
         "1/8 (12%)",
         "1.0",
         "1.0"
        ],
        [
         "Raynaud phenomenon [HP:0030880]",
         "2/9 (22%)",
         "0/2 (0%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent sinusitis [HP:0011108]",
         "2/9 (22%)",
         "1/8 (12%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent otitis media [HP:0000403]",
         "4/9 (44%)",
         "3/8 (38%)",
         "1.0",
         "1.0"
        ],
        [
         "Increased inflammatory response [HP:0012649]",
         "6/6 (100%)",
         "5/5 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgA concentration [HP:0410240]",
         "8/8 (100%)",
         "1/1 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Unusual infection [HP:0032101]",
         "8/8 (100%)",
         "5/5 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased specific antibody response to protein-conjugated polysaccharide vaccine [HP:0410302]",
         "8/9 (89%)",
         "2/2 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgG concentration [HP:0410242]",
         "9/9 (100%)",
         "2/2 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating antibody concentration [HP:0004313]",
         "9/9 (100%)",
         "2/2 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased specific antibody response to vaccination [HP:0032140]",
         "9/9 (100%)",
         "2/2 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating immunoglobulin concentration [HP:0010701]",
         "9/9 (100%)",
         "3/3 (100%)",
         "1.0",
         "1.0"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 24
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Allele group</th>\n",
       "      <th>p.Val85Asp</th>\n",
       "      <th>Other variant</th>\n",
       "      <th>Corrected p values</th>\n",
       "      <th>p values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Recurrent lower respiratory tract infections [HP:0002783]</th>\n",
       "      <td>6/6 (100%)</td>\n",
       "      <td>0/5 (0%)</td>\n",
       "      <td>0.051948</td>\n",
       "      <td>0.002165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elevated circulating creatinine concentration [HP:0003259]</th>\n",
       "      <td>0/4 (0%)</td>\n",
       "      <td>7/8 (88%)</td>\n",
       "      <td>0.080808</td>\n",
       "      <td>0.010101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anemia [HP:0001903]</th>\n",
       "      <td>0/4 (0%)</td>\n",
       "      <td>7/8 (88%)</td>\n",
       "      <td>0.080808</td>\n",
       "      <td>0.010101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent respiratory infections [HP:0002205]</th>\n",
       "      <td>6/6 (100%)</td>\n",
       "      <td>1/6 (17%)</td>\n",
       "      <td>0.087273</td>\n",
       "      <td>0.015152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgA concentration [HP:0002720]</th>\n",
       "      <td>8/9 (89%)</td>\n",
       "      <td>0/3 (0%)</td>\n",
       "      <td>0.087273</td>\n",
       "      <td>0.018182</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent infections [HP:0002719]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>5/10 (50%)</td>\n",
       "      <td>0.136364</td>\n",
       "      <td>0.035948</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating total IgM [HP:0002850]</th>\n",
       "      <td>7/9 (78%)</td>\n",
       "      <td>0/3 (0%)</td>\n",
       "      <td>0.136364</td>\n",
       "      <td>0.045455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgG concentration [HP:0004315]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>0.136364</td>\n",
       "      <td>0.045455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent upper respiratory tract infections [HP:0002788]</th>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>1/6 (17%)</td>\n",
       "      <td>0.285714</td>\n",
       "      <td>0.107143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sepsis [HP:0100806]</th>\n",
       "      <td>1/9 (11%)</td>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.454545</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Frequent Giardia lamblia infestation [HP:0005215]</th>\n",
       "      <td>1/9 (11%)</td>\n",
       "      <td>0/7 (0%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent bronchitis [HP:0002837]</th>\n",
       "      <td>1/9 (11%)</td>\n",
       "      <td>0/7 (0%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent tonsillitis [HP:0011110]</th>\n",
       "      <td>1/9 (11%)</td>\n",
       "      <td>1/8 (12%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Raynaud phenomenon [HP:0030880]</th>\n",
       "      <td>2/9 (22%)</td>\n",
       "      <td>0/2 (0%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent sinusitis [HP:0011108]</th>\n",
       "      <td>2/9 (22%)</td>\n",
       "      <td>1/8 (12%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent otitis media [HP:0000403]</th>\n",
       "      <td>4/9 (44%)</td>\n",
       "      <td>3/8 (38%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Increased inflammatory response [HP:0012649]</th>\n",
       "      <td>6/6 (100%)</td>\n",
       "      <td>5/5 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgA concentration [HP:0410240]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1/1 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Unusual infection [HP:0032101]</th>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>5/5 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased specific antibody response to protein-conjugated polysaccharide vaccine [HP:0410302]</th>\n",
       "      <td>8/9 (89%)</td>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgG concentration [HP:0410242]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating antibody concentration [HP:0004313]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased specific antibody response to vaccination [HP:0032140]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating immunoglobulin concentration [HP:0010701]</th>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Allele group                                        p.Val85Asp Other variant  \\\n",
       "Recurrent lower respiratory tract infections [H...  6/6 (100%)      0/5 (0%)   \n",
       "Elevated circulating creatinine concentration [...    0/4 (0%)     7/8 (88%)   \n",
       "Anemia [HP:0001903]                                   0/4 (0%)     7/8 (88%)   \n",
       "Recurrent respiratory infections [HP:0002205]       6/6 (100%)     1/6 (17%)   \n",
       "Decreased circulating IgA concentration [HP:000...   8/9 (89%)      0/3 (0%)   \n",
       "Recurrent infections [HP:0002719]                   8/8 (100%)    5/10 (50%)   \n",
       "Decreased circulating total IgM [HP:0002850]         7/9 (78%)      0/3 (0%)   \n",
       "Decreased circulating IgG concentration [HP:000...  9/9 (100%)     1/3 (33%)   \n",
       "Recurrent upper respiratory tract infections [H...  2/2 (100%)     1/6 (17%)   \n",
       "Sepsis [HP:0100806]                                  1/9 (11%)     1/3 (33%)   \n",
       "Frequent Giardia lamblia infestation [HP:0005215]    1/9 (11%)      0/7 (0%)   \n",
       "Recurrent bronchitis [HP:0002837]                    1/9 (11%)      0/7 (0%)   \n",
       "Recurrent tonsillitis [HP:0011110]                   1/9 (11%)     1/8 (12%)   \n",
       "Raynaud phenomenon [HP:0030880]                      2/9 (22%)      0/2 (0%)   \n",
       "Recurrent sinusitis [HP:0011108]                     2/9 (22%)     1/8 (12%)   \n",
       "Recurrent otitis media [HP:0000403]                  4/9 (44%)     3/8 (38%)   \n",
       "Increased inflammatory response [HP:0012649]        6/6 (100%)    5/5 (100%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...  8/8 (100%)    1/1 (100%)   \n",
       "Unusual infection [HP:0032101]                      8/8 (100%)    5/5 (100%)   \n",
       "Decreased specific antibody response to protein...   8/9 (89%)    2/2 (100%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...  9/9 (100%)    2/2 (100%)   \n",
       "Decreased circulating antibody concentration [H...  9/9 (100%)    2/2 (100%)   \n",
       "Decreased specific antibody response to vaccina...  9/9 (100%)    2/2 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  9/9 (100%)    3/3 (100%)   \n",
       "\n",
       "Allele group                                        Corrected p values  \\\n",
       "Recurrent lower respiratory tract infections [H...            0.051948   \n",
       "Elevated circulating creatinine concentration [...            0.080808   \n",
       "Anemia [HP:0001903]                                           0.080808   \n",
       "Recurrent respiratory infections [HP:0002205]                 0.087273   \n",
       "Decreased circulating IgA concentration [HP:000...            0.087273   \n",
       "Recurrent infections [HP:0002719]                             0.136364   \n",
       "Decreased circulating total IgM [HP:0002850]                  0.136364   \n",
       "Decreased circulating IgG concentration [HP:000...            0.136364   \n",
       "Recurrent upper respiratory tract infections [H...            0.285714   \n",
       "Sepsis [HP:0100806]                                           1.000000   \n",
       "Frequent Giardia lamblia infestation [HP:0005215]             1.000000   \n",
       "Recurrent bronchitis [HP:0002837]                             1.000000   \n",
       "Recurrent tonsillitis [HP:0011110]                            1.000000   \n",
       "Raynaud phenomenon [HP:0030880]                               1.000000   \n",
       "Recurrent sinusitis [HP:0011108]                              1.000000   \n",
       "Recurrent otitis media [HP:0000403]                           1.000000   \n",
       "Increased inflammatory response [HP:0012649]                  1.000000   \n",
       "Abnormal circulating IgA concentration [HP:0410...            1.000000   \n",
       "Unusual infection [HP:0032101]                                1.000000   \n",
       "Decreased specific antibody response to protein...            1.000000   \n",
       "Abnormal circulating IgG concentration [HP:0410...            1.000000   \n",
       "Decreased circulating antibody concentration [H...            1.000000   \n",
       "Decreased specific antibody response to vaccina...            1.000000   \n",
       "Abnormal circulating immunoglobulin concentrati...            1.000000   \n",
       "\n",
       "Allele group                                        p values  \n",
       "Recurrent lower respiratory tract infections [H...  0.002165  \n",
       "Elevated circulating creatinine concentration [...  0.010101  \n",
       "Anemia [HP:0001903]                                 0.010101  \n",
       "Recurrent respiratory infections [HP:0002205]       0.015152  \n",
       "Decreased circulating IgA concentration [HP:000...  0.018182  \n",
       "Recurrent infections [HP:0002719]                   0.035948  \n",
       "Decreased circulating total IgM [HP:0002850]        0.045455  \n",
       "Decreased circulating IgG concentration [HP:000...  0.045455  \n",
       "Recurrent upper respiratory tract infections [H...  0.107143  \n",
       "Sepsis [HP:0100806]                                 0.454545  \n",
       "Frequent Giardia lamblia infestation [HP:0005215]   1.000000  \n",
       "Recurrent bronchitis [HP:0002837]                   1.000000  \n",
       "Recurrent tonsillitis [HP:0011110]                  1.000000  \n",
       "Raynaud phenomenon [HP:0030880]                     1.000000  \n",
       "Recurrent sinusitis [HP:0011108]                    1.000000  \n",
       "Recurrent otitis media [HP:0000403]                 1.000000  \n",
       "Increased inflammatory response [HP:0012649]        1.000000  \n",
       "Abnormal circulating IgA concentration [HP:0410...  1.000000  \n",
       "Unusual infection [HP:0032101]                      1.000000  \n",
       "Decreased specific antibody response to protein...  1.000000  \n",
       "Abnormal circulating IgG concentration [HP:0410...  1.000000  \n",
       "Decreased circulating antibody concentration [H...  1.000000  \n",
       "Decreased specific antibody response to vaccina...  1.000000  \n",
       "Abnormal circulating immunoglobulin concentrati...  1.000000  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.view import summarize_hpo_analysis\n",
    "\n",
    "summarize_hpo_analysis(hpo=hpo, result=val85asp_result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "FEMALE",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "MALE",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Corrected p values",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "p values",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "0c55641b-9a78-4b34-8e46-68038684112c",
       "rows": [
        [
         "Decreased circulating IgA concentration [HP:0002720]",
         "1/4 (25%)",
         "7/8 (88%)",
         "1.0",
         "0.06666666666666667"
        ],
        [
         "Decreased circulating IgG concentration [HP:0004315]",
         "2/4 (50%)",
         "8/8 (100%)",
         "1.0",
         "0.09090909090909091"
        ],
        [
         "Decreased circulating total IgM [HP:0002850]",
         "1/4 (25%)",
         "6/8 (75%)",
         "1.0",
         "0.22222222222222224"
        ],
        [
         "Recurrent lower respiratory tract infections [HP:0002783]",
         "1/4 (25%)",
         "5/7 (71%)",
         "1.0",
         "0.24242424242424238"
        ],
        [
         "Decreased specific antibody response to protein-conjugated polysaccharide vaccine [HP:0410302]",
         "2/3 (67%)",
         "8/8 (100%)",
         "1.0",
         "0.27272727272727276"
        ],
        [
         "Elevated circulating creatinine concentration [HP:0003259]",
         "4/5 (80%)",
         "3/7 (43%)",
         "1.0",
         "0.29292929292929293"
        ],
        [
         "Anemia [HP:0001903]",
         "4/5 (80%)",
         "3/7 (43%)",
         "1.0",
         "0.29292929292929293"
        ],
        [
         "Recurrent infections [HP:0002719]",
         "4/7 (57%)",
         "9/11 (82%)",
         "1.0",
         "0.3259803921568627"
        ],
        [
         "Hyperuricemia [HP:0002149]",
         "4/5 (80%)",
         "1/3 (33%)",
         "1.0",
         "0.4642857142857142"
        ],
        [
         "Raynaud phenomenon [HP:0030880]",
         "1/3 (33%)",
         "1/8 (12%)",
         "1.0",
         "0.49090909090909096"
        ],
        [
         "Recurrent sinusitis [HP:0011108]",
         "2/7 (29%)",
         "1/10 (10%)",
         "1.0",
         "0.5367647058823529"
        ],
        [
         "Recurrent respiratory infections [HP:0002205]",
         "2/5 (40%)",
         "5/7 (71%)",
         "1.0",
         "0.558080808080808"
        ],
        [
         "Recurrent otitis media [HP:0000403]",
         "2/7 (29%)",
         "5/10 (50%)",
         "1.0",
         "0.622069107363225"
        ],
        [
         "Frequent Giardia lamblia infestation [HP:0005215]",
         "0/6 (0%)",
         "1/10 (10%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent bronchitis [HP:0002837]",
         "0/6 (0%)",
         "1/10 (10%)",
         "1.0",
         "1.0"
        ],
        [
         "Sepsis [HP:0100806]",
         "1/4 (25%)",
         "1/8 (12%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent tonsillitis [HP:0011110]",
         "1/7 (14%)",
         "1/10 (10%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgA concentration [HP:0410240]",
         "2/2 (100%)",
         "7/7 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased specific antibody response to polysaccharide vaccine [HP:0410299]",
         "2/2 (100%)",
         "7/7 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Recurrent upper respiratory tract infections [HP:0002788]",
         "2/5 (40%)",
         "1/3 (33%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating IgG concentration [HP:0410242]",
         "3/3 (100%)",
         "8/8 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased circulating antibody concentration [HP:0004313]",
         "3/3 (100%)",
         "8/8 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Decreased specific antibody response to vaccination [HP:0032140]",
         "3/3 (100%)",
         "8/8 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Neutropenia [HP:0001875]",
         "3/5 (60%)",
         "1/3 (33%)",
         "1.0",
         "1.0"
        ],
        [
         "Increased inflammatory response [HP:0012649]",
         "4/4 (100%)",
         "7/7 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating immunoglobulin concentration [HP:0010701]",
         "4/4 (100%)",
         "8/8 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Unusual infection [HP:0032101]",
         "4/4 (100%)",
         "9/9 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormality of the kidney [HP:0000077]",
         "5/5 (100%)",
         "3/3 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Abnormal circulating nitrogen compound concentration [HP:0004364]",
         "5/5 (100%)",
         "3/3 (100%)",
         "1.0",
         "1.0"
        ],
        [
         "Azotemia [HP:0002157]",
         "5/5 (100%)",
         "3/3 (100%)",
         "1.0",
         "1.0"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 30
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Sex</th>\n",
       "      <th>FEMALE</th>\n",
       "      <th>MALE</th>\n",
       "      <th>Corrected p values</th>\n",
       "      <th>p values</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgA concentration [HP:0002720]</th>\n",
       "      <td>1/4 (25%)</td>\n",
       "      <td>7/8 (88%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating IgG concentration [HP:0004315]</th>\n",
       "      <td>2/4 (50%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.090909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating total IgM [HP:0002850]</th>\n",
       "      <td>1/4 (25%)</td>\n",
       "      <td>6/8 (75%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.222222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent lower respiratory tract infections [HP:0002783]</th>\n",
       "      <td>1/4 (25%)</td>\n",
       "      <td>5/7 (71%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.242424</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased specific antibody response to protein-conjugated polysaccharide vaccine [HP:0410302]</th>\n",
       "      <td>2/3 (67%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.272727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elevated circulating creatinine concentration [HP:0003259]</th>\n",
       "      <td>4/5 (80%)</td>\n",
       "      <td>3/7 (43%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.292929</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anemia [HP:0001903]</th>\n",
       "      <td>4/5 (80%)</td>\n",
       "      <td>3/7 (43%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.292929</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent infections [HP:0002719]</th>\n",
       "      <td>4/7 (57%)</td>\n",
       "      <td>9/11 (82%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.325980</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Hyperuricemia [HP:0002149]</th>\n",
       "      <td>4/5 (80%)</td>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.464286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Raynaud phenomenon [HP:0030880]</th>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>1/8 (12%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.490909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent sinusitis [HP:0011108]</th>\n",
       "      <td>2/7 (29%)</td>\n",
       "      <td>1/10 (10%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.536765</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent respiratory infections [HP:0002205]</th>\n",
       "      <td>2/5 (40%)</td>\n",
       "      <td>5/7 (71%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.558081</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent otitis media [HP:0000403]</th>\n",
       "      <td>2/7 (29%)</td>\n",
       "      <td>5/10 (50%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.622069</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Frequent Giardia lamblia infestation [HP:0005215]</th>\n",
       "      <td>0/6 (0%)</td>\n",
       "      <td>1/10 (10%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent bronchitis [HP:0002837]</th>\n",
       "      <td>0/6 (0%)</td>\n",
       "      <td>1/10 (10%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sepsis [HP:0100806]</th>\n",
       "      <td>1/4 (25%)</td>\n",
       "      <td>1/8 (12%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent tonsillitis [HP:0011110]</th>\n",
       "      <td>1/7 (14%)</td>\n",
       "      <td>1/10 (10%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgA concentration [HP:0410240]</th>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>7/7 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased specific antibody response to polysaccharide vaccine [HP:0410299]</th>\n",
       "      <td>2/2 (100%)</td>\n",
       "      <td>7/7 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recurrent upper respiratory tract infections [HP:0002788]</th>\n",
       "      <td>2/5 (40%)</td>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating IgG concentration [HP:0410242]</th>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased circulating antibody concentration [HP:0004313]</th>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decreased specific antibody response to vaccination [HP:0032140]</th>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Neutropenia [HP:0001875]</th>\n",
       "      <td>3/5 (60%)</td>\n",
       "      <td>1/3 (33%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Increased inflammatory response [HP:0012649]</th>\n",
       "      <td>4/4 (100%)</td>\n",
       "      <td>7/7 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating immunoglobulin concentration [HP:0010701]</th>\n",
       "      <td>4/4 (100%)</td>\n",
       "      <td>8/8 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Unusual infection [HP:0032101]</th>\n",
       "      <td>4/4 (100%)</td>\n",
       "      <td>9/9 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormality of the kidney [HP:0000077]</th>\n",
       "      <td>5/5 (100%)</td>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Abnormal circulating nitrogen compound concentration [HP:0004364]</th>\n",
       "      <td>5/5 (100%)</td>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Azotemia [HP:0002157]</th>\n",
       "      <td>5/5 (100%)</td>\n",
       "      <td>3/3 (100%)</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Sex                                                     FEMALE        MALE  \\\n",
       "Decreased circulating IgA concentration [HP:000...   1/4 (25%)   7/8 (88%)   \n",
       "Decreased circulating IgG concentration [HP:000...   2/4 (50%)  8/8 (100%)   \n",
       "Decreased circulating total IgM [HP:0002850]         1/4 (25%)   6/8 (75%)   \n",
       "Recurrent lower respiratory tract infections [H...   1/4 (25%)   5/7 (71%)   \n",
       "Decreased specific antibody response to protein...   2/3 (67%)  8/8 (100%)   \n",
       "Elevated circulating creatinine concentration [...   4/5 (80%)   3/7 (43%)   \n",
       "Anemia [HP:0001903]                                  4/5 (80%)   3/7 (43%)   \n",
       "Recurrent infections [HP:0002719]                    4/7 (57%)  9/11 (82%)   \n",
       "Hyperuricemia [HP:0002149]                           4/5 (80%)   1/3 (33%)   \n",
       "Raynaud phenomenon [HP:0030880]                      1/3 (33%)   1/8 (12%)   \n",
       "Recurrent sinusitis [HP:0011108]                     2/7 (29%)  1/10 (10%)   \n",
       "Recurrent respiratory infections [HP:0002205]        2/5 (40%)   5/7 (71%)   \n",
       "Recurrent otitis media [HP:0000403]                  2/7 (29%)  5/10 (50%)   \n",
       "Frequent Giardia lamblia infestation [HP:0005215]     0/6 (0%)  1/10 (10%)   \n",
       "Recurrent bronchitis [HP:0002837]                     0/6 (0%)  1/10 (10%)   \n",
       "Sepsis [HP:0100806]                                  1/4 (25%)   1/8 (12%)   \n",
       "Recurrent tonsillitis [HP:0011110]                   1/7 (14%)  1/10 (10%)   \n",
       "Abnormal circulating IgA concentration [HP:0410...  2/2 (100%)  7/7 (100%)   \n",
       "Decreased specific antibody response to polysac...  2/2 (100%)  7/7 (100%)   \n",
       "Recurrent upper respiratory tract infections [H...   2/5 (40%)   1/3 (33%)   \n",
       "Abnormal circulating IgG concentration [HP:0410...  3/3 (100%)  8/8 (100%)   \n",
       "Decreased circulating antibody concentration [H...  3/3 (100%)  8/8 (100%)   \n",
       "Decreased specific antibody response to vaccina...  3/3 (100%)  8/8 (100%)   \n",
       "Neutropenia [HP:0001875]                             3/5 (60%)   1/3 (33%)   \n",
       "Increased inflammatory response [HP:0012649]        4/4 (100%)  7/7 (100%)   \n",
       "Abnormal circulating immunoglobulin concentrati...  4/4 (100%)  8/8 (100%)   \n",
       "Unusual infection [HP:0032101]                      4/4 (100%)  9/9 (100%)   \n",
       "Abnormality of the kidney [HP:0000077]              5/5 (100%)  3/3 (100%)   \n",
       "Abnormal circulating nitrogen compound concentr...  5/5 (100%)  3/3 (100%)   \n",
       "Azotemia [HP:0002157]                               5/5 (100%)  3/3 (100%)   \n",
       "\n",
       "Sex                                                 Corrected p values  \\\n",
       "Decreased circulating IgA concentration [HP:000...                 1.0   \n",
       "Decreased circulating IgG concentration [HP:000...                 1.0   \n",
       "Decreased circulating total IgM [HP:0002850]                       1.0   \n",
       "Recurrent lower respiratory tract infections [H...                 1.0   \n",
       "Decreased specific antibody response to protein...                 1.0   \n",
       "Elevated circulating creatinine concentration [...                 1.0   \n",
       "Anemia [HP:0001903]                                                1.0   \n",
       "Recurrent infections [HP:0002719]                                  1.0   \n",
       "Hyperuricemia [HP:0002149]                                         1.0   \n",
       "Raynaud phenomenon [HP:0030880]                                    1.0   \n",
       "Recurrent sinusitis [HP:0011108]                                   1.0   \n",
       "Recurrent respiratory infections [HP:0002205]                      1.0   \n",
       "Recurrent otitis media [HP:0000403]                                1.0   \n",
       "Frequent Giardia lamblia infestation [HP:0005215]                  1.0   \n",
       "Recurrent bronchitis [HP:0002837]                                  1.0   \n",
       "Sepsis [HP:0100806]                                                1.0   \n",
       "Recurrent tonsillitis [HP:0011110]                                 1.0   \n",
       "Abnormal circulating IgA concentration [HP:0410...                 1.0   \n",
       "Decreased specific antibody response to polysac...                 1.0   \n",
       "Recurrent upper respiratory tract infections [H...                 1.0   \n",
       "Abnormal circulating IgG concentration [HP:0410...                 1.0   \n",
       "Decreased circulating antibody concentration [H...                 1.0   \n",
       "Decreased specific antibody response to vaccina...                 1.0   \n",
       "Neutropenia [HP:0001875]                                           1.0   \n",
       "Increased inflammatory response [HP:0012649]                       1.0   \n",
       "Abnormal circulating immunoglobulin concentrati...                 1.0   \n",
       "Unusual infection [HP:0032101]                                     1.0   \n",
       "Abnormality of the kidney [HP:0000077]                             1.0   \n",
       "Abnormal circulating nitrogen compound concentr...                 1.0   \n",
       "Azotemia [HP:0002157]                                              1.0   \n",
       "\n",
       "Sex                                                 p values  \n",
       "Decreased circulating IgA concentration [HP:000...  0.066667  \n",
       "Decreased circulating IgG concentration [HP:000...  0.090909  \n",
       "Decreased circulating total IgM [HP:0002850]        0.222222  \n",
       "Recurrent lower respiratory tract infections [H...  0.242424  \n",
       "Decreased specific antibody response to protein...  0.272727  \n",
       "Elevated circulating creatinine concentration [...  0.292929  \n",
       "Anemia [HP:0001903]                                 0.292929  \n",
       "Recurrent infections [HP:0002719]                   0.325980  \n",
       "Hyperuricemia [HP:0002149]                          0.464286  \n",
       "Raynaud phenomenon [HP:0030880]                     0.490909  \n",
       "Recurrent sinusitis [HP:0011108]                    0.536765  \n",
       "Recurrent respiratory infections [HP:0002205]       0.558081  \n",
       "Recurrent otitis media [HP:0000403]                 0.622069  \n",
       "Frequent Giardia lamblia infestation [HP:0005215]   1.000000  \n",
       "Recurrent bronchitis [HP:0002837]                   1.000000  \n",
       "Sepsis [HP:0100806]                                 1.000000  \n",
       "Recurrent tonsillitis [HP:0011110]                  1.000000  \n",
       "Abnormal circulating IgA concentration [HP:0410...  1.000000  \n",
       "Decreased specific antibody response to polysac...  1.000000  \n",
       "Recurrent upper respiratory tract infections [H...  1.000000  \n",
       "Abnormal circulating IgG concentration [HP:0410...  1.000000  \n",
       "Decreased circulating antibody concentration [H...  1.000000  \n",
       "Decreased specific antibody response to vaccina...  1.000000  \n",
       "Neutropenia [HP:0001875]                            1.000000  \n",
       "Increased inflammatory response [HP:0012649]        1.000000  \n",
       "Abnormal circulating immunoglobulin concentrati...  1.000000  \n",
       "Unusual infection [HP:0032101]                      1.000000  \n",
       "Abnormality of the kidney [HP:0000077]              1.000000  \n",
       "Abnormal circulating nitrogen compound concentr...  1.000000  \n",
       "Azotemia [HP:0002157]                               1.000000  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpsea.analysis.clf import sex_classifier\n",
    "\n",
    "mf_result = analysis.compare_genotype_vs_phenotypes(\n",
    "    cohort=cohort,\n",
    "    gt_clf=sex_classifier(),\n",
    "    pheno_clfs=pheno_clfs,\n",
    ")\n",
    "\n",
    "summarize_hpo_analysis(hpo=hpo, result=mf_result)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "from gpseacs.report import GpseaAnalysisReport, GPAnalysisResultSummary\n",
    "\n",
    "fet_results = (\n",
    "    GPAnalysisResultSummary.from_multi(\n",
    "        result=val85asp_result,\n",
    "    ),\n",
    "    GPAnalysisResultSummary.from_multi(\n",
    "        result=mf_result,\n",
    "    ),\n",
    ")\n",
    "\n",
    "caption = \"\"\"The origin of clinical diversity in patients with SEC61A1 mutation is currently unclear. \n",
    "With our present patient set, a particular phenotype cannot be predicted on the basis of location or nature of the mutation \\\\cite{PMID_32325141}.\n",
    "\"\"\"\n",
    "report = GpseaAnalysisReport(name=gene_symbol, \n",
    "                             cohort=cohort, \n",
    "                             fet_results=fet_results,\n",
    "                             gene_symbol=gene_symbol,\n",
    "                             mane_tx_id=mane_tx_id,\n",
    "                             mane_protein_id=mane_protein_id,\n",
    "                             caption=caption)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<!DOCTYPE html>\n",
       "<html lang=\"en\">\n",
       "<head>\n",
       "  <meta charset=\"utf-8\">\n",
       "  <title>Cohort</title>\n",
       "    <style>\n",
       "    table {\n",
       "      border-collapse: collapse;\n",
       "      margin: 25px 0;\n",
       "      font-size: 0.9em;\n",
       "      font-family: sans-serif;\n",
       "      min-width: 400px;\n",
       "      box-shadow: 0 0 20px rgba(0, 0, 0, 0.15);\n",
       "    }\n",
       "\n",
       "    .table .column-1 {\n",
       "      text-align: left;\n",
       "    }\n",
       "    th {\n",
       "      background-color: LightSkyBlue;\n",
       "      border: 1px solid #dddddd;\n",
       "      text-align: left;\n",
       "      padding: 2px;\n",
       "      font-weight: bold;\n",
       "      font-size: 120%;\n",
       "      min-width: 100px;\n",
       "      border: 1px solid #ddd;\n",
       "      padding: 8px;\n",
       "        \n",
       "    }\n",
       "\n",
       "    tr {\n",
       "      border: 1px solid #dddddd;\n",
       "    }\n",
       "\n",
       "    td {\n",
       "      padding: 2px;\n",
       "      font-weight: bold;\n",
       "    }\n",
       "\n",
       "    tr:nth-child(even) {\n",
       "      background-color: #f2f2f2;\n",
       "    }\n",
       "\n",
       "    .table td, tr {\n",
       "      text-align: right;\n",
       "    }\n",
       "\n",
       "    .lft {\n",
       "      text-align: left;\n",
       "    }\n",
       "\n",
       "    div {\n",
       "      display: block;\n",
       "      width: 100%;\n",
       "      padding-right: 1%;\n",
       "      margin-bottom: 20px; /* Add margin to separate divs */\n",
       "    }\n",
       "\n",
       "    p {\n",
       "      width: 75%;\n",
       "    }\n",
       "\n",
       "    caption {\n",
       "      caption-side: top;\n",
       "      text-align: left;\n",
       "      padding-bottom: 10px;\n",
       "      font-weight: bold;\n",
       "    }\n",
       "  </style>\n",
       "</head>\n",
       "\n",
       "<body>\n",
       "  <h1>SEC61A1 Summary</h1>\n",
       "  <p>The cohort comprised 19 individuals (8 females, 11 males). 1 of these individuals were reported to be deceased. A total of 76 HPO terms were used to annotate the cohort. Disease diagnoses: Immunodeficiency, common variable, 15 (OMIM:620670) (11 individuals), Tubulointerstitial kidney disease, autosomal dominant, 5 (OMIM:617056) (7 individuals), Neutropenia, severe congenital, 11, autosomal dominant (OMIM:620674) (1 individuals). The origin of clinical diversity in patients with SEC61A1 mutation is currently unclear. \n",
       "With our present patient set, a particular phenotype cannot be predicted on the basis of location or nature of the mutation \\cite{PMID_32325141}.\n",
       " A total of 19 unique variant alleles were found in SEC61A1 (transcript: NM_013336.4, protein id: NP_037468.1). HPO version: 2025-01-16. GPSEA version: 0.9.6.dev0.</p>\n",
       "  \n",
       "  \n",
       "    \n",
       "      <table>\n",
       "        <caption style=\"color: black;\">\n",
       "            Fisher Exact Test performed to compare HPO annotation frequency with respect to p.Val85Asp and Other variant.\n",
       "        </caption>\n",
       "            <tbody>\n",
       "                <tr class=\"strng\">\n",
       "                    <th>Genotype (A)</th>\n",
       "                    <th>Genotype (B)</th>\n",
       "                  <th>Tests performed</th>\n",
       "                  <th>Significant tests</th>\n",
       "                </tr>\n",
       "                \n",
       "                <tr>\n",
       "                    <td class=\"lft\">p.Val85Asp</td>\n",
       "                    <td class=\"lft\">Other variant</td>\n",
       "                    <td class=\"lft\">24</td>\n",
       "                    <td class=\"lft\">0</td>\n",
       "                </tr>\n",
       "              </tbody>\n",
       "        </table>\n",
       "      \n",
       "\n",
       "  \n",
       "    \n",
       "      <table>\n",
       "        <caption style=\"color: black;\">\n",
       "            Fisher Exact Test performed to compare HPO annotation frequency with respect to FEMALE and MALE.\n",
       "        </caption>\n",
       "            <tbody>\n",
       "                <tr class=\"strng\">\n",
       "                    <th>Genotype (A)</th>\n",
       "                    <th>Genotype (B)</th>\n",
       "                  <th>Tests performed</th>\n",
       "                  <th>Significant tests</th>\n",
       "                </tr>\n",
       "                \n",
       "                <tr>\n",
       "                    <td class=\"lft\">FEMALE</td>\n",
       "                    <td class=\"lft\">MALE</td>\n",
       "                    <td class=\"lft\">30</td>\n",
       "                    <td class=\"lft\">0</td>\n",
       "                </tr>\n",
       "              </tbody>\n",
       "        </table>\n",
       "      \n",
       "\n",
       "  \n",
       "  \n",
       "  \n",
       "  \n",
       "  \n",
       "\n",
       "\n",
       "\n",
       "</body>\n",
       "</html>"
      ],
      "text/plain": [
       "<gpseacs.report._api.HtmlGpseaNotebookSummarizer at 0x7e8deb0d4290>"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from gpseacs.report import GpseaNotebookSummarizer\n",
    "summarizer = GpseaNotebookSummarizer(hpo=hpo, gpsea_version=gpsea.__version__)\n",
    "summarizer.summarize_report(report=report)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Figure saved to ../../supplement/img/SEC61A1_protein_diagram-draft.pdf\n",
      "Output to ../../supplement/tex/SEC61A1_summary_draft.tex\n"
     ]
    }
   ],
   "source": [
    "summarizer.process_latex(report=report, protein_fig=sec61a1_fig)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
